Non-Steroidal or Opioid Analgesia Use for Children With Musculoskeletal Injuries

PHASE2CompletedINTERVENTIONAL
Enrollment

710

Participants

Timeline

Start Date

April 20, 2019

Primary Completion Date

March 9, 2023

Study Completion Date

March 22, 2023

Conditions
Musculoskeletal Injury
Interventions
DRUG

Ibuprofen

10mg/kg, maximum 600mg; Oral liquid

DRUG

Acetaminophen

15mg/kg, maximum 1000mg; Oral liquid

DRUG

Hydromorphone

0.05mg/kg, maximum 5 mg; Oral liquid

DRUG

Acetaminophen placebo

Oral liquid

DRUG

Hydromorphone placebo

Oral liquid

Trial Locations (6)

T3B 6A9

Alberta Children's Hospital, Calgary

T6G 2B7

Stollery Children's Hospital Emergency Department, Edmonton

R3A 1S1

Children's Hospital of Winnipeg, Winnipeg

N6A 5W9

Childrens Hospital at London Health Sciences, London

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

HT3 1C5

CHU Sainte-Justine, Montreal

All Listed Sponsors
collaborator

University of Manitoba

OTHER

collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

collaborator

University of Calgary

OTHER

collaborator

The Hospital for Sick Children

OTHER

collaborator

University of Ottawa

OTHER

collaborator

Western University

OTHER

lead

University of Alberta

OTHER

NCT03767933 - Non-Steroidal or Opioid Analgesia Use for Children With Musculoskeletal Injuries | Biotech Hunter | Biotech Hunter